Physician profile
Evan K Yoo
NPI 1912388661
$1,272.91
in general payments reported to CMS, 2019-2025
23 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.91 · 2020: $49.41 · 2021: $222 · 2022: $229 · 2023: $312 · 2024: $222 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polymedics Innovations INC. | $142.31 | 2023 | |
| Smith+Nephew, INC. | $138.64 | 2020-2025 | Collagenase Santyl |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $123.84 | 2021-2024 | Jublia |
| Amgen INC. | $105.03 | 2024-2025 | Krystexxa |
| Molecular Biologicals, INC | $81.51 | 2021 | |
| Paratek Pharmaceuticals, INC. | $75.05 | 2021-2024 | Nuzyra |
| Grt US Holding, INC. | $58.14 | 2022 | |
| Averitas Pharma INC. | $57.28 | 2023-2025 | Qutenza |
| Nevro Corp. | $53.42 | 2023-2024 | Senza |
| Sebela Pharmaceuticals INC. | $53.27 | 2022-2023 | Naftin |
| Abbvie INC. | $51.36 | 2023-2024 | Dalvance |
| Cashflow Solutions, LLC | $47.74 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Melinta Therapeutics, LLC | $46.41 | 2021-2022 | |
| Ibsa Pharma INC. | $42.09 | 2023-2024 | Tirosint, Licart, Tirosint |
| Bioventus LLC | $38.67 | 2019-2024 | Exogen Ultrasound Bone Healing System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $28.78 | 2025 | Flexitouch Plus, Nimbl |
| Zimmer Biomet Holdings, INC. | $26.96 | 2021 | |
| Ge Healthcare | $25.00 | 2020 | |
| Orthofix Medical, INC. | $22.10 | 2023 | Physio-Stim, Spinal-Stim |
| Horizon Therapeutics Plc | $17.28 | 2021 | |
| Globus Medical, INC. | $14.28 | 2025 | Senza |
| Biowound Solutions, INC. | $12.50 | 2025 | Bio-Connekt |
| Merck Sharp & Dohme LLC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.